P2RY13 and acute myeloid leukemia: However, previous studies reported that P2RY13 expression in acute myeloid leukemia was increased, and regulated cyclic adenosine monophosphate-mediated cytarabine resistance (Aroua et al., 2020; Maiga et al., 2016).